Search

Search Constraints

You searched for: Record Type Journal Article Author/Creator Guilabert, A.

Search Results

2. Corrigendum to "Genetically defined variants of toll-like receptors 3, 7 and 9 as phenotype and risk modifier factors for psoriasis" [89 (March (3)) (2018) 301–304]. Issue 3 (September 2018)

3. Cutaneous reactions after SARS‐CoV‐2 vaccination: a cross‐sectional Spanish nationwide study of 405 cases. (1st January 2022)

4. Cutaneous reactions after SARS‐CoV‐2 vaccination: a cross‐sectional Spanish nationwide study of 405 cases. (21st September 2021)

5. Genetically defined variants of toll-like receptors 3, 7 and 9 as phenotype and risk modifier factors for psoriasis. Issue 3 (March 2018)

8. Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria. (1st July 2018)

9. Omalizumab updosing allows disease activity control in patients with refractory chronic spontaneous urticaria. (25th April 2018)